The 24-h FEV1time profile of olodaterol once daily via Respimat® and formoterol twice daily via Aerolizer® in patients with GOLD 2–4 COPD: results from two 6-week crossover studies
Gregory J Feldman,Jonathan A Bernstein,Alan Hamilton,Michael C Nivens…Volume:
3
Language:
english
Journal:
SpringerPlus
DOI:
10.1186/2193-1801-3-419
Date:
December, 2014
File:
PDF, 524 KB
english, 2014